For more than 50 years, the Asthma and Allergy Foundation of America (AAFA) has been dedicated to improving the quality of life for people with asthma and allergic diseases through education, advocacy and research. This dedication is most evident every May, which the organization declares as “National Asthma and Allergy Awareness Month.”
AstraZeneca urges Americans to embrace National Asthma and Allergy Awareness Month and to learn more about the impact these diseases can have on people’s lives.
Approximately 25 million Americans, including 7 million children, suffer from asthma. The number of people who are affected by this chronic disease, which affects the airways and lungs, is increasing. The Centers for Disease Control and Prevention estimates that in the last 10 years the proportion of people living with asthma in the United States has grown by nearly 15 percent.
Allergies are the sixth leading cause of chronic illness in the United States and impact more than 50 million Americans each year. Indoor allergens are one type of trigger that can affect an individual’s asthma. Triggers can cause asthma symptoms or lead to an attack. It is important to note these triggers, which include second hand smoke, dust mites, mold, pets and outdoor air pollution.
While May is the dedicated month for asthma and allergy awareness, AstraZeneca, the AAFA and other advocacy groups across the nation work to bring awareness to the many Americans who suffer from asthma and allergies throughout the year.
There are steps that individuals can take to control their asthma through appropriate care. To access helpful asthma resources, including information on asthma triggers and steps that may help prevent asthma attacks, visit the EPA’s website .
To learn more about National Asthma and Allergy Awareness month and to see how you can be involved this May, visit www.aafa.org